Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
12.41
-0.65 (-4.98%)
Apr 30, 2025, 3:00 PM CST
Hainan Huluwa Pharmaceutical Group Company Description
Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other therapeutic in China.
It offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products.
The company was founded in 2005 and is based in Haikou, China.
Hainan Huluwa Pharmaceutical Group Co., Ltd.
Country | China |
Founded | 2005 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 2,468 |
CEO | Jinping Liu |
Contact Details
Address: No. 8, Yaogu 4th Road Haikou, 570311 China | |
Phone | 86 898 6868 9766 |
Website | huluwayaoye.com |
Stock Details
Ticker Symbol | 605199 |
Exchange | Shanghai Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE100004223 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Jinping Liu | GM and Chairman of the Board |
Qingtao Wang | Secretary |
Tianbao Wei | Deputy General Manager |
Wei Li | Accounting Supervisor |